175 related articles for article (PubMed ID: 31337965)
1. Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients.
Qian X; Nguyen DT; Dong Y; Sinikovic B; Kaufmann AM; Myers JN; Albers AE; Graviss EA
Int J Biol Sci; 2019; 15(7):1336-1344. PubMed ID: 31337965
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus RNA Transcript Associates with Prognosis in Non-human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma.
Tang B; Zhu G; Chen C; Zheng S; Pu Y; Xu Y; Huang H; Wang G; Huang D; Liu Y; Zhang X
Laryngoscope; 2021 Aug; 131(8):1774-1781. PubMed ID: 33592124
[TBL] [Abstract][Full Text] [Related]
3. Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC.
Gui S; O'Neill WQ; Teknos TN; Pan Q
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737336
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
5. Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma.
Ren H; Li H; Li P; Xu Y; Liu G; Sun L
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32500914
[TBL] [Abstract][Full Text] [Related]
6. Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients.
Nguyen DT; Jenkins HE; Graviss EA
PLoS One; 2018; 13(4):e0196022. PubMed ID: 29659636
[TBL] [Abstract][Full Text] [Related]
7. Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma.
Chen L; Zeng H; Zhang M; Luo Y; Ma X
Cancer Med; 2021 Jul; 10(13):4615-4628. PubMed ID: 33987946
[TBL] [Abstract][Full Text] [Related]
8. A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection.
Hess J; Unger K; Maihoefer C; Schüttrumpf L; Wintergerst L; Heider T; Weber P; Marschner S; Braselmann H; Samaga D; Kuger S; Pflugradt U; Baumeister P; Walch A; Woischke C; Kirchner T; Werner M; Werner K; Baumann M; Budach V; Combs SE; Debus J; Grosu AL; Krause M; Linge A; Rödel C; Stuschke M; Zips D; Zitzelsberger H; Ganswindt U; Henke M; Belka C
Clin Cancer Res; 2019 Mar; 25(5):1505-1516. PubMed ID: 30171046
[TBL] [Abstract][Full Text] [Related]
9.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
11. Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma.
Hartman DJ; Ahmad F; Ferris RL; Rimm DL; Pantanowitz L
Oral Oncol; 2018 Nov; 86():278-287. PubMed ID: 30409313
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.
De Cecco L; Bossi P; Locati L; Canevari S; Licitra L
Ann Oncol; 2014 Aug; 25(8):1628-35. PubMed ID: 24827125
[TBL] [Abstract][Full Text] [Related]
13. A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival.
Shen S; Bai J; Wei Y; Wang G; Li Q; Zhang R; Duan W; Yang S; Du M; Zhao Y; Christiani DC; Chen F
Oncol Rep; 2017 Dec; 38(6):3403-3411. PubMed ID: 29130107
[TBL] [Abstract][Full Text] [Related]
14. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.
Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167
[TBL] [Abstract][Full Text] [Related]
15. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
[TBL] [Abstract][Full Text] [Related]
17. HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.
Wookey VB; Appiah AK; Kallam A; Ernani V; Smith LM; Ganti AK
Anticancer Res; 2019 Apr; 39(4):1907-1914. PubMed ID: 30952732
[TBL] [Abstract][Full Text] [Related]
18. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X
Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Predictive Scoring System for 90-Day Mortality Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Completed Concurrent Chemoradiotherapy.
Lin KC; Chen TM; Yuan KS; Wu ATH; Wu SY
JAMA Netw Open; 2020 Mar; 3(3):e1920671. PubMed ID: 32215631
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]